The U.S. Small Business Administration is offering low-interest federal disaster loans for working capital to Arizona small businesses suffering substantial economic injury as a result of the Coronavirus. Loans are available for for profit and nonprofit businesses.Continue reading
Author Archive: AZBio
BIO Launches Coronavirus Hub to Facilitate Exchange of Supplies & Services
The new Coronavirus Hub connects those companies that have relevant supplies, capacities, and resources to share, with those companies, researchers, or healthcare providers that need them. The new hub will enable users to post requests for urgently needed items, as well as to post the availability of supplies and capacityContinue reading
Funding Opportunities: National Institute on Aging at NIH
The National Institute on Aging at NIH (NIA) posted six new Funding Opportunity Announcements in February. Check out what’s new.Continue reading
Gilead Sciences Update On The Company’s Ongoing Response To COVID-19
Gilead is working closely with global health authorities to respond to the novel coronavirus (COVID-19) outbreak through the appropriate experimental use of the investigational compound remdesivir. Together with the U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS), National Institute of Allergies and Infectious Diseases (NIAID) and Department of Defense (DoD) – CBRN Medical; the China CDC and National Medical Product Administration (NMPA); the World Health Organization (WHO); and individual researchers and clinicians; Gilead is focused on contributing our antiviral expertise and resources to help patients and communities fighting COVID-19.Continue reading
COVID-19 is Changing the Way We Live and Work. How Do We Cope?
University of Arizona psychologist David Sbarra shares tips for how to take care of your mental health and support children and loved ones in an uncertain time.Continue reading
FDA Grants Plasmology4® “Breakthrough Device Designation” for the Treatment of Multidrug-Refractory Bacteria
On February 12, 2020, Plasmology4®, Inc., a leader in Plasma Medicine, announced that the company’s product has been granted into the U.S. Food and Drug Administration’s (FDA) Breakthrough Devices Program for the treatment of “multidrug-refractory bacterial and/or fungal pathogen bioburden in a wound bed.”Continue reading
Medtronic Continuing to Increase Ventilator Production to Address COVID-19 Pandemic
DUBLIN, March 18, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, continues to make progress in increasing ventilator production worldwide. The company has increased production by more than 40 percent to date and is on track to more than double its capacity to manufacture and supply ventilators in response to the urgent needs of patients and healthcare systems across the globe confronting COVID-19.
BD, BioGX Announce FDA Emergency Use Authorization Submissions for New COVID-19 Diagnostics for Use in U.S.
New Diagnostics Have Potential to Increase Capacity of COVID-19 Testing in U.S. by Thousands of Tests Per DayContinue reading
FDA Issues Diagnostic Emergency Use Authorization to Hologic and LabCorp
On March 16, 2020, the U.S. Food and Drug Administration took two additional significant diagnostic actions during the coronavirus outbreak (COVID-19) by issuing Emergency Use Authorizations (EUAs) to: Hologic for its Panther Fusion SARS-COV-2 Assay, and Laboratory Corporation of America (LabCorp) for its COVID-19 RT-PCR test.Continue reading
Flinn Foundation issues grant to support COVID-19 testing, cancels events
Responding to the COVID-19 pandemic, the Phoenix-based Flinn Foundation has issued an emergency $100,000 grant to the Translational Genomics Research Institute (TGen) to support population-based testing of the novel coronavirus in Arizona and to help TGen immediately and dramatically ramp up its capacity to analyze individual samples for the disease. Continue reading